2018 American Transplant Congress
Long-Term Nonhuman Primate Renal Allograft Survival without Ongoing Immunosuppression in Recipients of Delayed Donor Bone Marrow Transplantation
Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA.
Background: We have previously reported induction of renal allograft tolerance in nonhuman primates following an initial post-transplant period of conventional immunosuppression (IS) using a nonmyeloablative…2018 American Transplant Congress
New Sensitive Markers for Early Diagnosis of Transplant Glomerulopathy in Kidney Recipients
Chronic antibody mediated rejection (ABMR) with Transplant glomerulopathy (TG) remains a major contributor of renal graft loss in the long term. New sensitive markers are…2018 American Transplant Congress
Race and Socioeconomic Disparities in Organ Type, Recovery and Readmission in Kidney Transplant Recipients
Glickman Urology and Nephrology, Cleveland Clinic, Cleveland.
Objectives: Racial and socioeconomic disparities are prevalent in healthcare, including for kidney transplant recipients. Post-transplant, patients are faced with many challenges that contribute to high…2018 American Transplant Congress
Improving Participation in Non-A1/Non-A1B to B Deceased Donor Program Post Kidney Allocation System (KAS)- A Single Center Experience
Blood type B kidney transplant candidates have a longer wait time on the deceased donor list, an average of 6 years compared to 3 years…2018 American Transplant Congress
Once-Daily versus Twice-Daily Tacrolimus in De Novo Living Kidney Transplantation Patients: A Multicenter, Parallel Group, Open-Label, 5-Year Randomized Noninferiority Trial
BackgroundTacrolimus is available as twice-daily (TAC-BID) and once-daily (TAC-QD) formulations. Findings from pharmacokinetic and short-term trials are available. However, results from long-term trials are limited.We…2018 American Transplant Congress
Durable Donor Hematopoetic Stem Cell (HSC) Chimerism is Associated with Protection from Native Renal Disease Recurrence in Recipients of Combined HSC/Kidney Transplants
1Northwestern U, Chicago; 2U Louisville, Louisville.
Recurrence of the original cause of ESRD has been observed in trials of tolerance induction for kidney transplantation (KTx) where donor HSC have been used…2018 American Transplant Congress
Outcomes in Renal Transplant Recipients with Bipolar Disorder: A Large Retrospective Cohort
Purpose: Management of renal transplant recipients (RTRs) with bipolar disorder (BD) is complicated by risk factors for non-adherence, complex medication regimens and limited published guidance.…2018 American Transplant Congress
Long-Term Follow-Up of Pediatric Kidney Recipients Who Received Alemtuzumab Induction
Introduction: Experience with alemtuzumab (alem) depleting antibody induction has rarely been studied in the pediatric population, and reports that exist have limited follow-up. The purpose…2018 American Transplant Congress
Long-Term Outcome of Pediatric Kidney Transplantation: A Single-Center Experience over the past Three Decades in Japan
Purpose: Kidney transplantation (KTx) is the preferred treatment for children with ESRD. Although the steady advances in immunosuppression have enabled control of early acute rejection…2018 American Transplant Congress
Overcoming Barriers to Transplant: An A2 to B Program Need Not Be Difficult, Expensive, or Time Consuming Even for Large Centers
Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington, DC.
Introduction. Since the implementation of the new Kidney Allocation System (KAS) few centers have implemented the use of A2 donor kidneys into B recipients. Centers…
- « Previous Page
- 1
- …
- 261
- 262
- 263
- 264
- 265
- …
- 531
- Next Page »